Breakthrough Technologies for Optogenetics

  • Lightweight
  • Battery Free
  • Implantable
  • Ultraminiaturized

NeuroLux News

posted: 2017-10-19

NeuroLux awarded NIH STTR Phase I Grant

NeuroLux, an early stage biotech company based in Champaign, IL, has been awarded a Small Business Technology Transfer (STTR) Phase I grant by the National Institutes of Health (NIH) to develop wireless, battery-free devices for programmable fluid delivery and optogenetic stimulation, in designs fully compatible with the existing NeuroLux HF wireless electronic platform and control […]

posted: 2017-10-11

NeuroLux Spinal Optogenetics System Published in PAIN!

This new wireless platform that adapts near-field communication (NFC) technology and microscale LED technologies for optogenetic studies beyond the brain. The reported devices are designed specifically for implantation in a minimally invasive fashion over the mouse spinal cord for wireless and battery-free optogenetic interrogation of spinal circuits in freely moving animals. The studies utilized NeuroLux […]

posted: 2017-11-02

Anthony Banks is Guest Speaker at University of Illinois Office of Technology Management’s Share the Vision 2017

Anthony Banks, one of the co-founders and the vice president of NeuroLux, Inc., will deliver a talk on innovative discovery tools for medical research as one of the guest speakers for Share the Vision 2017 on September 21, 2017, at the EnterpriseWorks Startup Incubator. The event is a startup showcase hosted by the Office of […]

Full News Archive